GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Abbott Laboratories (Pakistan) Ltd (KAR:ABOT) » Definitions » Change In Other Working Capital

Abbott Laboratories (Pakistan) (KAR:ABOT) Change In Other Working Capital : ₨-2,796 Mil (TTM As of Mar. 2025)


View and export this data going back to 1982. Start your Free Trial

What is Abbott Laboratories (Pakistan) Change In Other Working Capital?

Abbott Laboratories (Pakistan)'s Change In Other Working Capital for the quarter that ended in Mar. 2025 was ₨95 Mil. It means Abbott Laboratories (Pakistan)'s Other Working Capital increased by ₨95 Mil from Dec. 2024 to Mar. 2025 .

Abbott Laboratories (Pakistan)'s Change In Other Working Capital for the fiscal year that ended in Dec. 2024 was ₨-4,140 Mil. It means Abbott Laboratories (Pakistan)'s Other Working Capital declined by ₨4,140 Mil from Dec. 2023 to Dec. 2024 .


Abbott Laboratories (Pakistan) Change In Other Working Capital Historical Data

The historical data trend for Abbott Laboratories (Pakistan)'s Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbott Laboratories (Pakistan) Change In Other Working Capital Chart

Abbott Laboratories (Pakistan) Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Change In Other Working Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,069.33 2,459.27 2,827.00 4,189.22 -4,139.81

Abbott Laboratories (Pakistan) Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Change In Other Working Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,248.04 -1,015.11 -337.15 -1,539.51 95.33

Abbott Laboratories (Pakistan) Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₨-2,796 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Abbott Laboratories (Pakistan) Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of Abbott Laboratories (Pakistan)'s Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Abbott Laboratories (Pakistan) Business Description

Traded in Other Exchanges
N/A
Address
Hyderabad Road, Landhi, P.O. Box 7229, Plot No. 258 & 324, Opposite Radio Pakistan Transmission Centre, Karachi, PAK, 75120
Abbott Laboratories (Pakistan) Ltd manufactures, imports, and markets research-based pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products. Its operating segments are Pharmaceutical, Nutritional, Diagnostics, and Others. It generates maximum revenue from the Pharmaceutical segment. Geographically, it derives the majority of its revenue from Pakistan and has a presence in Afghanistan, Sri Lanka, Bangladesh, and Switzerland. Its Brands include Duphaston, Brufen, Surbex Z, Arinac, Glucerna, Pediasure, and Ensure.

Abbott Laboratories (Pakistan) Headlines

No Headlines